EDITORIAL
Published on 07 Apr 2022
Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity
doi 10.3389/fmolb.2022.859821
- 957 views
- 3 citations
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds with a High Level of Selectivity of Action and Low Toxicity
Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds with a High Level of Selectivity of Action and Low Toxicity
7,031
Total downloads
33k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 01 Dec 2021
1H -NMR Metabolomics Study of the Effect of Cisplatin and Casiopeina IIgly on MDA-MB-231 Breast Tumor Cells
doi 10.3389/fmolb.2021.742859
- 2,035 views
- 11 citations
ORIGINAL RESEARCH
Published on 04 Jun 2021
IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
doi 10.3389/fmolb.2021.675179
- 11,233 views
- 28 citations
REVIEW
Published on 04 Feb 2021
Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency
doi 10.3389/fmolb.2020.627272
- 14,278 views
- 99 citations
ORIGINAL RESEARCH
Published on 12 Jan 2021
The Influence of Some Axial Ligands on Ruthenium–Phthalocyanine Complexes: Chemical, Photochemical, and Photobiological Properties
doi 10.3389/fmolb.2020.595830
- 3,143 views
- 8 citations
Published in
Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
Impact
- 33kTopic views
- 26kArticle views
- 7,031Article downloads